Abstract
To evaluate the effect of azathioprine with steroids on the clinical course and histologic parameters of severe Henoch-Schönlein nephritis (HSN), 20 patients with a median age of 9.3 years (range 4.4–17 years) and a follow-up period of 4.8 years (range 1–14 years) were included in this study. The patients were divided into two groups. Ten patients received azathioprine with steroids for 8 months (group A), and the other ten received steroids alone (group B). All patients underwent renal biopsy at presentation, and ten of them who were treated with azathioprine underwent follow-up biopsy after therapy. Six patients in group A achieved clinical remission, and the remaining four showed minor urinary abnormalities at the latest observation. The histological grades of the International Study of Kidney Disease in Children (ISKDC) improved in four of the ten patients, and the activity index decreased significantly from 6.8±2.0 to 4.3±2.3 (p=0.016). In group B, however, four patients had normal urine and renal function; two had minor urinary abnormalities; one had active renal disease, and three had chronic renal insufficiency, at the latest observation. The combination treatment of azathioprine and steroids may be beneficial in ameliorating histopathological features and improving the clinical course of severe HSN.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura. A retrospective cohort study. Lancet 360:666–670
Austin HA, Balow JE (1983) Henoch-Schönlein nephritis: prognostic features and the challenge of therapy. Am J Kidney Dis 2:512–520
Goldstein AR, White RHR, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339:280–282
Öner A, Tinaztepe K, Erdogan Ö (1995) The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 9:6–10
Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch nephritis. Pediatr Nephrol 12:238–243
Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12:244–248
Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S (2003) Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 18:347–350
Bergstein J, Leiser J, Andreoli SP (1998) Response of crescentic HSP nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 49:9–14
Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe HSP nephritis with prednisone and azathioprine: a clinical and histopathological study. J Pediatr 136:370–375
Singh S, Devidayal, Kumar L, Joshi K, Minz RW, Datta U (2002) Severe Henoch-Schönlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 22:133–137
National Heart, Lung, and Blood Institute (1987) Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics 79:1–25
Counahan R, Winterborn MH, White RHR, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch-Schönlein nephritis in children. Br Med J 2:11–14
Andreoli S, Bergstein J (1989) Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248–253
Meadow SR, Glasgow EF, White RHR, Moncrief MW, Cameron JS, Ogg CS (1972) Schönlein-Henoch nephritis. Q J Med 41:241–258
Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FB (1996) Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Nephrol Dial Transplant 12:2277–2283
Rai A, Nast C, Adler S (1999) Henoch-Schönlein purpura nephritis. J Am Soc Nephrol 10:2637–2644
Rieu P, Noel LH (1999) Henoch-Schönlein nephritis in children and adults: Morphological features and clinicopathological correlations. Ann Med Interne (Paris) 150:151–159
Tarshish P, Bernstein J, Edelmann CM (2004) Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 19:51–56
Ronkainen J, Ala-Houhala M, Huttunen N-P, Jahnukainen T, Koskimies O, Örmälä T, Nuutinen M (2003) Outcome of Henoch-Schönlein nephritis with nephrotic-range proteinuria. Clin Nephrol 60:80–84
Ronkainen J, Autio-Harmainen H, Nuutinen M (2003) Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. Pediatr Nephrol 18:1138–1142
Faedda R, Pirisi M, Satta A, Bosincu L, Bartoli E (1996) Regression of Henoch-Schönlein disease with intensive immunosuppressive treatment. Clin Pharmacol Ther 60:576–581
Levy M, Broyer M, Arsan A, Levy Bentolila D, Habib R (1976) Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hosp 6:183–228
Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M et al (1999) A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 10:101–109
Bohle A, Mackensen-Haen S, von Gise H (1990) The consequences of tubulo-interstitial changes for renal function in glomerulopathies: a morphometric and cytological analysis. Pathol Res Pract 186:135–144
Bohle A, Wehrmann M, Bogenschutz O (1992) The long-term prognosis of the primary glomerulonephritides: a morphological and clinical analysis of 1,747 cases. Pathol Res Pract 188:908–924
Bohle A, Wehrmann M, Mackensen-Haen S (1994) Pathogenesis of chronic renal failure in primary glomerulopathies. Nephrol Dial Transplant 3 [Suppl]:4–12
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shin, J.I., Park, J.M., Shin, Y.H. et al. Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children?. Pediatr Nephrol 20, 1087–1092 (2005). https://doi.org/10.1007/s00467-005-1869-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-1869-x